Thomas P. Mathers, Chief Executive Officer at CoLucid Pharmaceuticals, Inc. (CLCD), sold 1,502 shares at $34.25 ($52K) on 2017-01-05, disclosed to the SEC on 2017-01-05.
Scheduled sale ($52k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.25 | 802 | $27K | 52.6% |
| 2 | $34.86 | 200 | $7K | 13.3% |
| 3 | $35.60 | 500 | $18K | 34.1% |
| Total | $34.78 avg | 1,502 | $52K | 100% |
| Filing → |
| CLCD | SELL | 2016-10-05 | $111K | — | Filing → |
| CLCD | SELL | 2016-09-16 | $140K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $201K | — | Filing → |